Supplemental Table 3.
Variable | Combined primary fetal and neonatal endpoint |
||
---|---|---|---|
n (column %) | Crude or only BMI (aOR [95% CI])a | Multivariable (aOR [95% CI])b | |
Model 1 | |||
GDM) | |||
No GDM or preexisting DM | 126 (9.8) | Ref | Ref |
GDM, no DM | 1159 (90.2) | 1.21 (0.76–1.92) | 1.12 (0.70–1.81) |
BMIc | |||
Underweight or normal weight (<25 kg/m2) | 690 (53.7) | Ref | Ref |
Overweight (≥25 kg/m2) | 336 (26.2) | 1.96 (1.39–2.76)d | 1.87 (1.31–2.67)d |
Obese (≥30 kg/m2) | 259 (20.2) | 1.81 (1.24–2.65)d | 1.72 (1.15–2.56)d |
Model 2 | |||
No GDM or DM, underweight or normal weight | 660 (51.4) | Ref | Ref |
No GDM or DM, overweight | 292 (22.7) | 2.01 (1.40–2.88)d | 1.92 (1.32–2.80)d |
No GDM or DM, obese | 207 (16.1) | 1.93 (1.29–2.90)d | 1.88 (1.23–2.87)d |
GDM, underweight or normal weight | 30 (2.3) | 1.79 (0.71–4.50) | 1.90 (0.75–4.83) |
GDM, overweight | 44 (3.4) | 2.38 (1.16–4.90)d | 2.16 (1.01–4.59)d |
GDM, obese | 52 (4.1) | 1.92 (0.95–3.88) | 1.57 (0.75–3.30) |
Data are presented as aOR (95% CI) using logistic regression analyses with combined primary offspring endpoint (yes or no) as the dependent variable.
aOR, odds ratio; BMI, body mass index; CI, confidence interval; DM, diabetes mellitus; GDM, gestational diabetes mellitus; Ref, reference interval.
Kleinwechter. Gestational diabetes mellitus and COVID-19: COVID-19–Related Obstetric and Neonatal Outcome Study registry results. Am J Obstet Gynecol 2022.
Model 1 adjusted for BMI only and model 2 unadjusted
Additionally adjusted for week of gestation at the onset of COVID-19 symptoms (or at a positive polymerase chain reaction test result), multiples (yes or no), maternal age at positive COVID-19 test result, language competence (communication possible with or without problems), nicotine or smoking during pregnancy (yes or no), parity (0 or ≥1), and hypertensive disorders in pregnancy (yes or no)
Maternal BMI before or at the beginning of pregnancy (kg/m2)
P<.05.